Australia markets open in 8 hours 34 minutes

G1 Therapeutics, Inc. (G1H.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.9040+0.0260 (+0.67%)
As of 08:00AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7778
Avg. Estimate-0.99-0.99-3.63-3.63
Low estimate-1.07-1.1-3.77-4.23
High estimate-0.92-0.84-3.35-2.99
Year ago EPS-0.31-0.67-2.62-3.63
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7778
Avg. Estimate5.79M9.89M32.3M60.28M
Low estimate4M5.69M14.23M29.29M
High estimate8M14M42.82M72.9M
Year ago sales26.6M16.55M45.28M32.3M
Sales growth (year/est)-78.20%-40.20%-28.70%86.60%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.3-0.9-1.07-0.97
Actual EPS-0.31-0.67-0.65-0.94
Difference-0.010.230.420.03
Surprise %-3.30%25.60%39.30%3.10%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.99-0.99-3.63-3.63
7 days ago-0.99-0.99-3.63-3.63
30 days ago-0.96-0.95-3.53-3.42
60 days ago-0.95-0.92-3.49-3.43
90 days ago-0.95-0.92-3.49-3.43
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesG1H.FIndustrySector(s)S&P 500
Current qtr.-219.40%N/AN/AN/A
Next qtr.-47.80%N/AN/AN/A
Current year-38.50%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A